Logo
DCA

Becton, Dickinson and Company

sp500
BDXHealthcareMedical Instruments & Supplies
144,43 $US
-0.62%
Letzter Preis
144,43 $US
2026-06-02
24h Änderung
-0.62%
-0.90 USD
Volumen
2,1 Mio.
Gehandelte Anteile
Datenzuverlässigkeit
Hoch
13433 Punkte (53 Jahre)

Kursentwicklung

Starten Sie eine Simulation mit diesem Asset

BDX

Globale Parameter

Verfügbare Daten von 21.2.1973 bis 2.6.2026

Fundamentalanalyse

New
CAGR (5y)
4.99%
Revenue Growth
Net Margin
7.68%
Profitability
ROE
6.61%
Return on Equity
Debt / EBITDA
3.87
Solvency
PEG Ratio
1.15
Valuation vs Growth
Rev. Growth (TTM)
1.60%
Current Trend

KGV-Historie (5 Jahre)

Historical PE
Average (40.0x)
Current: 24.4x
Technischer Fokus
BDX
30d-Volatilität
26.04%
Abstand zur MA50
-4.41%
Abstand zur MA200
-19.60%
Abstand zum ATH
-49.07%
Momentum 3M
-15.78%
Risiko-Score
N/A

Moderate Volatilität. Momentum neutral.

Über Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

In diesen Wert investieren
Kaufen bei Saxo Bank
🏦Regulierter Broker
🌍Globaler Marktzugang
📈Profi-Tools

Werbelink. Kapital unterliegt Risiken.

Technische Analyse & Risiko

Schlüsselkennzahlen

CAGR8.11%
Volatilität26.04%
Max Drawdown-49.80%

Momentum : BDX

Indicateur synthétique
PEURNEUTREAVIDITÉ
40
Fear

Risikoanalyse

VaR (95%)-2.39%
DCA Gesundheit
86/100

Jüngste Geschichte (60 Tage)

DatumSchlusskursVolumen
2026-06-02144,43 $US2.085.837
2026-06-01145,33 $US2.353.996
2026-05-29147,12 $US3.658.099
2026-05-28148,41 $US2.456.040
2026-05-27147,24 $US2.878.200
2026-05-26147,75 $US3.243.481
2026-05-22147,63 $US1.004.167
2026-05-21146,25 $US1.574.560
2026-05-20146,95 $US2.057.077
2026-05-19146,95 $US3.053.565
2026-05-18142,35 $US3.773.030
2026-05-15143,47 $US4.277.310
2026-05-14144,47 $US2.319.158
2026-05-13144,18 $US3.650.067
2026-05-12147,51 $US3.465.234
2026-05-11143,15 $US3.378.688
2026-05-08149,43 $US4.019.734
2026-05-07153,26 $US5.132.482
2026-05-06144,76 $US3.399.234
2026-05-05144,17 $US2.810.660
2026-05-04146,31 $US1.925.651
2026-05-01149,31 $US1.818.077
2026-04-30149,04 $US1.943.949
2026-04-29145,31 $US2.917.648
2026-04-28149,52 $US2.094.893
2026-04-27150,22 $US2.681.313
2026-04-24152,14 $US1.729.488
2026-04-23154,85 $US2.664.370
2026-04-22155,65 $US1.957.052
2026-04-21156,69 $US3.209.625
2026-04-20158,64 $US3.235.577
2026-04-17158,54 $US2.832.669
2026-04-16154,82 $US3.372.109
2026-04-15155,52 $US2.013.286
2026-04-14155,73 $US2.338.838
2026-04-13155,43 $US2.880.880
2026-04-10154,22 $US1.694.892
2026-04-09155,46 $US1.995.252
2026-04-08157,09 $US2.186.904
2026-04-07154,96 $US1.365.096
2026-04-06155,32 $US1.875.904
2026-04-02154,51 $US1.822.914
2026-04-01156,34 $US1.620.945
2026-03-31157,23 $US1.769.376
2026-03-30154,69 $US1.498.843
2026-03-27154,51 $US1.855.730
2026-03-26157,38 $US2.369.969
2026-03-25158,27 $US1.323.500
2026-03-24155,92 $US2.218.350
2026-03-23156,23 $US1.652.406
2026-03-20154,13 $US3.722.926
2026-03-19156,53 $US1.638.944
2026-03-18158,08 $US1.681.443
2026-03-17161,64 $US2.154.435
2026-03-16160,27 $US2.184.032
2026-03-13159,36 $US1.939.747
2026-03-12159,63 $US2.372.988
2026-03-11163,17 $US3.219.144
2026-03-10163,88 $US2.528.200
2026-03-09165,46 $US2.343.646

Jüngste Dividenden

DatumBetrag
2026-03-10+1,05 $US
2025-12-08+1,05 $US
2025-09-08+1,04 $US
2025-06-09+1,04 $US
2025-03-10+1,04 $US
2024-12-09+1,04 $US
2024-09-09+0,95 $US
2024-06-10+0,95 $US
2024-03-07+0,95 $US
2023-12-07+0,95 $US
2023-09-07+0,91 $US
2023-06-08+0,91 $US
2023-03-09+0,91 $US
2022-12-08+0,91 $US
2022-09-08+0,87 $US
2022-06-08+0,87 $US
2022-03-09+0,85 $US
2021-12-09+0,85 $US
2021-09-08+0,81 $US
2021-06-08+0,81 $US

Verwandte Assets